MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,835 | +64.4% | 317,601 | +36.4% | 0.02% | +81.8% |
| Q2 2023 | $8,413 | -2.6% | 232,860 | +0.3% | 0.01% | -8.3% |
| Q1 2023 | $8,634 | -17.6% | 232,217 | +0.4% | 0.01% | -14.3% |
| Q4 2022 | $10,484 | -99.9% | 231,382 | +28.0% | 0.01% | -22.2% |
| Q3 2022 | $12,622,000 | +3.1% | 180,732 | -0.9% | 0.02% | +12.5% |
| Q2 2022 | $12,241,000 | +24.8% | 182,342 | +52.9% | 0.02% | +60.0% |
| Q1 2022 | $9,807,000 | +22.0% | 119,283 | +117.7% | 0.01% | +25.0% |
| Q4 2021 | $8,039,000 | -13.3% | 54,803 | +4.6% | 0.01% | -20.0% |
| Q3 2021 | $9,268,000 | +12.2% | 52,388 | +2.5% | 0.01% | +11.1% |
| Q2 2021 | $8,258,000 | +26.9% | 51,125 | +34.5% | 0.01% | +28.6% |
| Q1 2021 | $6,509,000 | -34.0% | 38,000 | -15.4% | 0.01% | -36.4% |
| Q4 2020 | $9,868,000 | +45.2% | 44,930 | +9.8% | 0.01% | +37.5% |
| Q3 2020 | $6,796,000 | +76.6% | 40,930 | +21.5% | 0.01% | +60.0% |
| Q2 2020 | $3,848,000 | +94.0% | 33,700 | +30.6% | 0.01% | +66.7% |
| Q1 2020 | $1,983,000 | -37.2% | 25,800 | +5.3% | 0.00% | -25.0% |
| Q4 2019 | $3,157,000 | +42.7% | 24,500 | -13.7% | 0.00% | +33.3% |
| Q3 2019 | $2,213,000 | -16.1% | 28,400 | +10.9% | 0.00% | 0.0% |
| Q2 2019 | $2,637,000 | +76.4% | 25,600 | +25.5% | 0.00% | +50.0% |
| Q1 2019 | $1,495,000 | +72.8% | 20,400 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $865,000 | -18.0% | 20,400 | -8.9% | 0.00% | 0.0% |
| Q3 2018 | $1,055,000 | +5.9% | 22,400 | +10.9% | 0.00% | 0.0% |
| Q2 2018 | $996,000 | +1506.5% | 20,200 | +69.7% | 0.00% | – |
| Q1 2017 | $62,000 | +8.8% | 11,901 | +0.0% | 0.00% | – |
| Q4 2016 | $57,000 | -27.8% | 11,900 | 0.0% | 0.00% | – |
| Q3 2016 | $79,000 | +21.5% | 11,900 | 0.0% | 0.00% | – |
| Q2 2016 | $65,000 | -74.5% | 11,900 | 0.0% | 0.00% | – |
| Q1 2016 | $255,000 | -32.2% | 11,900 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $376,000 | +11.6% | 11,900 | +21.4% | 0.00% | 0.0% |
| Q3 2015 | $337,000 | +7.3% | 9,800 | -1.7% | 0.00% | – |
| Q2 2015 | $314,000 | – | 9,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |